Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Arndt

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
BMJ Open Respiratory Research|August 23, 2024
Non-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancerMichael Cekay, Philipp F Arndt, Johanna K Franken, et al.
Mayo Clinic Proceedings|September 4, 2022
Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019Raymund R Razonable, John C O'Horo, Douglas W Challener, et al.
Nature Genetics|May 19, 2015
Genome-wide patterns and properties of de novo mutations in humansLaurent C Francioli, Paz P Polak, Amnon Koren, et al.
Annals of the American Thoracic Society|March 5, 2025
Echocardiographic Measure of Right Ventricular-pulmonary Arterial Coupling Predicts Survival in Lung CancerZvonimir A Rako, Michael Cekay, Athiththan Yogeswaran, et al.
The Journal of Infectious Diseases|July 19, 2021
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, et al.
The Journal of Clinical Investigation|August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.
Cancer Cell|August 15, 2018
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell CarcinomaRaj K Gopal, Kirsten Kübler, Sarah E Calvo, et al.
Nature Genetics|May 21, 2025
Genomic landscape of multiple myeloma and its precursor conditionsJean-Baptiste Alberge, Ankit K Dutta, Andrea Poletti, et al.
Mayo Clinic Proceedings|May 7, 2021
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic ModelRaymund R Razonable, Nicole C E Aloia, Ryan J Anderson, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
BMJ Open Respiratory Research|August 23, 2024
Non-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancerMichael Cekay, Philipp F Arndt, Johanna K Franken, et al.
Mayo Clinic Proceedings|September 4, 2022
Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019Raymund R Razonable, John C O'Horo, Douglas W Challener, et al.
Nature Genetics|May 19, 2015
Genome-wide patterns and properties of de novo mutations in humansLaurent C Francioli, Paz P Polak, Amnon Koren, et al.
Annals of the American Thoracic Society|March 5, 2025
Echocardiographic Measure of Right Ventricular-pulmonary Arterial Coupling Predicts Survival in Lung CancerZvonimir A Rako, Michael Cekay, Athiththan Yogeswaran, et al.
The Journal of Infectious Diseases|July 19, 2021
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, et al.
The Journal of Clinical Investigation|August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.
Cancer Cell|August 15, 2018
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell CarcinomaRaj K Gopal, Kirsten Kübler, Sarah E Calvo, et al.
Nature Genetics|May 21, 2025
Genomic landscape of multiple myeloma and its precursor conditionsJean-Baptiste Alberge, Ankit K Dutta, Andrea Poletti, et al.
Mayo Clinic Proceedings|May 7, 2021
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic ModelRaymund R Razonable, Nicole C E Aloia, Ryan J Anderson, et al.
Pageof 12